{"first_name":"John","last_name":"Onopchenko","permalink":"john-onopchenko","crunchbase_url":"http://www.crunchbase.com/person/john-onopchenko","homepage_url":null,"birthplace":null,"twitter_username":null,"blog_url":null,"blog_feed_url":null,"affiliation_name":"Unaffiliated","born_year":null,"born_month":null,"born_day":null,"tag_list":null,"alias_list":null,"created_at":"Thu Dec 31 04:00:06 UTC 2009","updated_at":"Thu Dec 31 04:04:00 UTC 2009","overview":"<p>John Onopchenko is a co-founder of Synergy Life Science Partners. Prior to co-founding Synergy, John was Vice President and lead medical device investor with Johnson &amp; Johnsonâ€™s venture capital subsidiary, Johnson &amp; Johnson Development Corporation (â€œJJDCâ€). Additionally, John served on the Management Committee of JJDC. His portfolio company realizations include: Epicor, Novacept, Digirad (NASDAQ: DRAD), Genyx, Nuvasive (NASDAQ: NUVA), Vascular Control Systems, Vivant Medical and Volcano Corporation (NASDAQ: VOLC). </p>","image":{"available_sizes":[[[150,106],"assets/images/resized/0007/1652/71652v1-max-150x150.jpg"],[[172,122],"assets/images/resized/0007/1652/71652v1-max-250x250.jpg"],[[172,122],"assets/images/resized/0007/1652/71652v1-max-450x450.jpg"]],"attribution":""},"degrees":[{"degree_type":"M.B.A.","subject":"","institution":"University of Chicago","graduated_year":null,"graduated_month":null,"graduated_day":null}],"relationships":[{"is_past":false,"title":"Managing Director","firm":{"name":"Synergy Life Science Partner","permalink":"synergy-life-sciences-partner","type_of_entity":"financial_org","image":{"available_sizes":[[[150,41],"assets/images/resized/0004/9515/49515v2-max-150x150.jpg"],[[250,69],"assets/images/resized/0004/9515/49515v2-max-250x250.jpg"],[[322,90],"assets/images/resized/0004/9515/49515v2-max-450x450.jpg"]],"attribution":null}}}],"investments":[],"milestones":[],"video_embeds":[],"external_links":[],"web_presences":[]}